PDL BioPharma Inc (NASDAQ:PDLI)

6.62
BATS BZX Real-Time Price
As of 9:48am ET
 -0.02 / -0.30%
Today’s Change
6.38
Today|||52-Week Range
10.26
-14.14%
Year-to-Date

Today’s Trading

Previous close6.64
Today’s open6.63
Day’s range6.61 - 6.64
Volume50,625
Average volume (3 months)4,042,132
Market cap$1.1B
Dividend yield9.05%
Data as of 9:34am ET, 05/22/2015

Growth & Valuation

Earnings growth (last year)+12.05%
Earnings growth (this year)+13.17%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)+31.23%
P/E ratio3.5
Price/Sales2.10
Price/Book2.34

Competitors

 Today’s
change
Today’s
% change
FOLDAmicus Therapeutics ...+0.04+0.35%
ACHNAchillion Pharmaceut...+0.01+0.05%
CLLSCellectis SA+1.76+5.71%
TXMDTherapeuticsMD Inc+0.08+1.22%
Data as of 9:48am ET, 05/22/2015

Financials

Next reporting dateJuly 29, 2015
EPS forecast (this quarter)$0.52
Annual revenue (last year)$581.2M
Annual profit (last year)$322.2M
Net profit margin55.44%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John Peter McLaughlin
Chief Financial Officer &
Vice President
Peter S. Garcia
Corporate headquarters
Incline Village, Nevada

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers